Literature DB >> 15911856

Is daily inhaled steroid use necessary in the treatment of mild persistent asthma?

Matthew B Stanbrook1.   

Abstract

Entities:  

Year:  2005        PMID： 15911856      PMCID： PMC557977          DOI： 10.1503/cmaj.050515

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  2 in total

1.  Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial.

Authors:  P M O'Byrne; P J Barnes; R Rodriguez-Roisin; E Runnerstrom; T Sandstrom; K Svensson; A Tattersfield
Journal:  Am J Respir Crit Care Med       Date:  2001-10-15       Impact factor: 21.405

2.  Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial.

Authors:  Romain A Pauwels; Søren Pedersen; William W Busse; Wan C Tan; Yu-Zhi Chen; Stefan V Ohlsson; Anders Ullman; Carl Johan Lamm; Paul M O'Byrne
Journal:  Lancet       Date:  2003-03-29       Impact factor: 79.321
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.